Department of Medicinal Chemistry and Key Laboratory of Chemical Biology of Natural Products (MOE), School of Pharmacy , Shandong University , Jinan , Shandong 250012 , China.
Department of Chemistry , New York University , New York , New York 10003 , United States.
J Chem Inf Model. 2018 Nov 26;58(11):2331-2342. doi: 10.1021/acs.jcim.8b00548. Epub 2018 Oct 19.
Accurate protein structure in the ligand-bound state is a prerequisite for successful structure-based virtual screening (SBVS). Therefore, applications of SBVS against targets for which only an apo structure is available may be severely limited. To address this constraint, we developed a computational strategy to explore the ligand-bound state of a target protein, by combined use of molecular dynamics simulation, MM/GBSA binding energy calculation, and fragment-centric topographical mapping. Our computational strategy is validated against low-molecular weight protein tyrosine phosphatase (LMW-PTP) and then successfully employed in the SBVS against protein tyrosine phosphatase receptor type O (PTPRO), a potential therapeutic target for various diseases. The most potent hit compound GP03 showed an IC value of 2.89 μM for PTPRO and possessed a certain degree of selectivity toward other protein phosphatases. Importantly, we also found that neglecting the ligand energy penalty upon binding partially accounts for the false positive SBVS hits. The preliminary structure-activity relationships of GP03 analogs are also reported.
准确的配体结合状态下的蛋白质结构是成功进行基于结构的虚拟筛选 (SBVS) 的前提。因此,对于仅具有 apo 结构的靶标,SBVS 的应用可能会受到严重限制。为了解决这个限制,我们开发了一种计算策略,通过分子动力学模拟、MM/GBSA 结合能计算和基于片段的拓扑映射的组合,探索靶标蛋白的配体结合状态。我们的计算策略针对低分子量蛋白酪氨酸磷酸酶 (LMW-PTP) 进行了验证,然后成功应用于针对蛋白酪氨酸磷酸酶受体型 O (PTPRO) 的 SBVS,PTPRO 是多种疾病的潜在治疗靶标。最有效的命中化合物 GP03 对 PTPRO 的 IC 值为 2.89 μM,对其他蛋白磷酸酶具有一定的选择性。重要的是,我们还发现,在配体结合时忽略配体能量罚分部分解释了 SBVS 假阳性命中的原因。还报告了 GP03 类似物的初步结构-活性关系。